Published in
Elsevier, Cancer Letters, (461), p. 102-111, 2019
DOI: 10.1016/j.canlet.2019.07.004
Links
Tools
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
Journal article published in 2019 by
Joseph J. Caumanns,
Anne van Wijngaarden,
Arjan Kol,
Gert J. Meersma,
Mathilde Jalving 
,
René Bernards,
Ate G. J. van der Zee,
G. Bea A. Wisman,
Steven de Jong
,
René Bernards,
Ate G. J. van der Zee,
G. Bea A. Wisman,
Steven de Jong
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 